Quantcast

Latest Aspirin Stories

2014-04-21 20:21:44

INDIANAPOLIS, April 21, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA(TM) (ramucirumab) as a single-agent treatment for patients with advanced or metastatic gastric cancer or gastroesophageal junction (GEJ) adenocarcinoma with disease progression on or after prior fluoropyrimidine- or platinum-containing chemotherapy. With this approval, CYRAMZA becomes the first FDA-approved treatment for patients...

2014-04-09 08:28:11

Company Launches Second Innovative Offering to Accompany 'Pain Relief' Formula SEATTLE, April 9, 2014 /PRNewswire/ -- First Aid Shot Therapy, makers of First Aid Shot Therapy Pain Relief, today announced the launch of its newest offering, First Aid Shot Therapy Upset Stomach. Upset Stomach is the second variant to be launched in the F.A.S.T. range of products and it is formulated to relive upset stomach symptoms. It comes in a great-tasting, smooth, ready-to-drink, liquid shot form, which...

Pregnant Women With High Risk For Preeclampsia Should Be On Low-Dose Aspirin Regimen: Study
2014-04-08 14:08:39

Brett Smith for redOrbit.com - Your Universe Online Marked by high blood pressure and elevated levels of protein in the urine, preeclampsia is the leading cause of death for pregnant women. New guidelines released by the US Preventative Services Task Force now recommend that pregnant women at high risk for preeclampsia take a steady low dose of aspirin as a preventative measure starting after 12 weeks of pregnancy. High-risk women include those who have a history with the condition,...

2014-04-07 13:07:48

The Effects of Aspirin in Gestation and Reproduction (EAGeR) medical trial has found that, in general, low-dose aspirin is not beneficial for future pregnancy outcomes in women with prior pregnancy loss. However, in women with one pregnancy loss within the previous 12 months, there did appear to be a benefit. Jean Wactawski-Wende, PhD, professor in the Department of Epidemiology and Environmental Health in the School of Public Health and Health Professions at the University at Buffalo,...

2014-04-02 08:32:38

BRANFORD, Conn., April 2, 2014 /PRNewswire/ -- New Haven Pharmaceuticals, Inc. (the "Company"), a privately held specialty pharmaceuticals company, today announced the appointment of Larry Dillaha, M.D., to the newly-created position of Executive Vice President Operations. Dr. Dillaha joins the Company from Insys Therapeutics, Inc. (Nasdaq: INSY) where he served as Chief Medical Officer since April 2010. "We are delighted to welcome Larry, who will provide significant insight and...

2014-04-01 13:06:26

Bottom Line: Taking low doses of aspirin (which inhibits platelet function) after a colon cancer diagnosis appears to be associated with better survival if the tumor cells express HLA class I antigen. Author: Marlies S. Reimers, M.D., Leiden University Medical Center, the Netherlands, and colleagues. Background: Prior research has suggested aspirin use after a colorectal cancer diagnosis might improve survival. Although the precise mechanism of aspirin's anti-cancer effect is unknown,...

2014-03-31 08:29:45

RARITAN, N.J., March 31, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today it is adding three new clinical trials to its EXPLORER global cardiovascular research program for XARELTO(®) (rivaroxaban), the most studied and broadly indicated oral Factor Xa inhibitor in the world today. The additional trials will evaluate rivaroxaban for the treatment or prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) in pediatric and other patient...

2014-03-13 12:29:35

LONDON, March 13, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: MediPoint: Renal Denervation - EU Analysis and Market Forecasts MediPoint: Renal Denervation - EU Analysis and Market Forecasts SummaryNumerous medical device news sources and industry executives have proclaimed renal denervation to be the top medical device breakthrough of the past two years, and for good reason. Hypertension is one of the most prevalent chronic conditions...

2014-03-12 08:31:57

Inventors Earn 50 Percent of Licensing Royalties for Successfully Commercialized Ideas CHARLOTTE, N.C., March 12, 2014 /PRNewswire/ -- Edison Nation Medical, a medical device incubator and healthcare innovation portal, is launching a global search to uncover innovative ideas for improving the design, packaging and administration of medications as a way to address the issue of accidental poisonings. This search coincides with National Poison Prevention Week, which takes place March 16...

2014-03-07 16:22:47

NASHVILLE, Tenn., March 7, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced that data from a recent study evaluating the efficacy and safety of Caldolor(®) (ibuprofen) Injection will be presented at the Pediatric Anesthesiology 2014 conference in Fort Lauderdale, Florida. The pediatric study met its primary endpoint demonstrating that Caldolor was associated with a statistically significant reduction in temperature within the first 2 hours of...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related